Citizens maintains $30 price target on Intellia Therapeutics
Citizens maintained its $30.00/share price target for Intellia Therapeutics.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Citizens maintained its $30.00/share price target for Intellia Therapeutics.